Insulet Corporation
PODD
#1897
Rank
$9.944 B
Marketcap
United States
Country
$143.38
Share price
-0.91%
Change (1 day)
-57.21%
Change (1 year)
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values…
Key Metrics
Trailing P/E
26.38
Forward P/E
18.23
EPS (TTM)
$5.33
Forward EPS
$7.71
Price / Book
6.86
EV / EBITDA
16.6x
Beta
1.08
Dividend Yield
—
Return on Equity
26.02%
Return on Assets
9.71%
Debt / Equity
66.69
Current Ratio
2.48
Gross Margin
71.08%
Operating Margin
16.18%
Net Profit Margin
12.29%
Free Cash Flow
$236.900M
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 18
-7.20%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$2.708B
Latest Net Income$247.100M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Insulet Corporation with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
PODD
No recent news available. Set FINNHUB_API_KEY to enable news.
